AB817: Bill Text

AB817,60,19 (d) Not more than 300 milligrams of hydrocodone per 100 milliliters or per 100 grams or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; .

AB817,60,22 (e) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or per 100 grams or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; .

AB817,60,25 (f) Not more than 300 milligrams of ethylmorphine per 100 milliliters or per 100 grams or not more than 15 milligrams per dosage unit, with one or more ingredients in recognized therapeutic amounts;.

AB817, s. 199 Section 199. 161.18 (6) of the statutes is renumbered 961.18 (6) and amended to read:

AB817,61,11 961.18 (6) Exceptions. The controlled substances board may except by rule any compound, mixture or preparation containing any stimulant or depressant substance listed included in sub. (2m) or (3) from the application of all or any part of this chapter if the compound, mixture or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.

AB817, s. 200 Section 200. 161.18 (7) of the statutes is renumbered 961.18 (7), and 961.18 (7) (intro.), as renumbered, is amended to read:

AB817,61,19 961.18 (7) (title) Anabolic Steroids steroids. (intro.) Any material, compound, mixture, or preparation containing any quantity of any of the following anabolic steroids, including any of their esters, isomers, esters of isomers, salts and salts of esters, isomers and esters of isomers, whenever those esters, isomers, esters of isomers, salts and salts, esters, isomers and esters of isomers exist that are theoretically possible within the specific chemical designation:

AB817, s. 201 Section 201. 161.19 (title) of the statutes is renumbered 961.19 (title).

AB817, s. 202 Section 202. 161.19 of the statutes is renumbered 961.19 (1m), and 961.19 (1m) (intro.), (a) and (c), as renumbered, are amended to read:

AB817,61,24 961.19 (1m) (intro.) The controlled substances board shall place add a substance in to schedule IV if it finds upon finding that:

AB817,62,2 (a) The substance has a low potential for abuse relative to substances included in schedule III;

AB817,62,4 (c) Abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances included in schedule III.

AB817, s. 203 Section 203. 161.20 (title) of the statutes is renumbered 961.20 (title).

AB817, s. 204 Section 204. 161.20 (1) (title) of the statutes is repealed.

AB817, s. 205 Section 205. 161.20 (1) of the statutes is renumbered 961.20 (intro.) and amended to read:

AB817,62,11 961.20 (intro.) The Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in this section are included in schedule IV.:

AB817, s. 206 Section 206. 161.20 (2) of the statutes is renumbered 961.20 (2), and 961.20 (2) (intro.) and (h), as renumbered, are amended to read:

AB817,62,19 961.20 (2) Depressants. (intro.) Unless specifically excepted under federal regulations or unless listed in another schedule, any Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system or, including any of their salts, isomers or and salts of isomers, if salts, isomers or salts of isomers exist under that are theoretically possible within the specific chemical designation:

AB817,62,20 (h) Methylphenobarbital, which is also called mephobarbital;

AB817, s. 207 Section 207. 161.20 (2m) (intro.) of the statutes is renumbered 961.20 (2m) (intro.) and amended to read:

AB817,63,3 961.20 (2m) Stimulants. (intro.) Unless specifically excepted under federal regulations or unless listed in another schedule, any Any material, compound, mixture, or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system or, including any of their salts, isomers or and salts of isomers, if salts, isomers or salts of isomers exist under that are theoretically possible within the specific chemical designation:

AB817, s. 208 Section 208. 161.20 (2m) (a) of the statutes is renumbered 961.20 (2m) (a).

AB817, s. 209 Section 209. 161.20 (2m) (ag) of the statutes is renumbered 961.20 (2m) (ag) and amended to read:

AB817,63,8 961.20 (2m) (ag) N,N-dimethyl-1-1,2-diphenylethylamine N,N-dimethyl-1,2-diphenylethylamine, commonly known as "SPA";.

AB817, s. 210 Section 210. 161.20 (2m) (ar) of the statutes is renumbered 961.20 (2m) (ar) and amended to read:

AB817,63,11 961.20 (2m) (ar) Fencamfamine;.

AB817, s. 211 Section 211. 161.20 (2m) (b) of the statutes is renumbered 961.20 (4) (am) and amended to read:

AB817,63,14 961.20 (4) (am) Fenfluramine, including any of its isomers and salts of isomers.

AB817, s. 212 Section 212. 161.20 (2m) (bm) of the statutes is renumbered 961.20 (2m) (bm) and amended to read:

AB817,63,17 961.20 (2m) (bm) Mazindol;.

AB817, s. 213 Section 213. 161.20 (2m) (c) of the statutes is renumbered 961.20 (2m) (c) and amended to read:

AB817,63,20 961.20 (2m) (c) Pemoline, including its organometallic complexes and chelates.

AB817, s. 214 Section 214. 161.20 (2m) (d) of the statutes is renumbered 961.20 (2m) (d).

AB817, s. 215 Section 215. 161.20 (2m) (e) of the statutes is renumbered 961.20 (2m) (e).

AB817, s. 216 Section 216. 161.20 (3) of the statutes is renumbered 961.20 (3), and 961.20 (3) (intro.), as renumbered, is amended to read:

AB817,64,8 961.20 (3) Narcotic drugs containing nonnarcotic active medicinal ingredients. (intro.) Any compound, mixture or preparation containing limited quantities of any of the following narcotic drugs or their salts, isomers or salts of isomers, in limited quantities as set forth below, calculated as the free anhydrous base or alkaloid, which also contains one or more nonnarcotic, active medicinal ingredients in sufficient proportion to confer upon the compound, mixture or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

AB817, s. 217 Section 217. 161.20 (3m) (title) of the statutes is repealed.

AB817, s. 218 Section 218. 161.20 (3m) of the statutes is renumbered 961.20 (2m) (ak) and amended to read:

AB817,64,18 961.20 (2m) (ak) Unless specifically excepted under federal regulations or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of ephedrine or a salt of ephedrine, an optical isomer of ephedrine or a salt of an optical isomer of ephedrine. This subsection applies only Ephedrine, if the ephedrine, salt, optical isomer or salt of the optical isomer is the only active medicinal ingredient or if there are only therapeutically insignificant quantities of another active medicinal ingredient.

AB817, s. 219 Section 219. 161.20 (4) of the statutes is renumbered 961.20 (4), and 961.20 (4) (intro.) and (b), as renumbered, are amended to read:

AB817,64,24 961.20 (4) Other substances. (intro.) Unless specifically excepted under federal regulations or unless listed in another schedule, any Any material, compound, mixture or preparation which contains any quantity of any of the following substances or their salts:

AB817,64,25 (b) Pentazocine, including any of its isomers and salts of isomers.

AB817, s. 220 Section 220. 161.20 (5) of the statutes is renumbered 961.20 (5) and amended to read:

AB817,65,10 961.20 (5) Exceptions. The controlled substances board may except by rule any compound, mixture or preparation containing any depressant substance listed included in sub. (2) from the application of all or any part of this chapter if the compound, mixture or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances which have a depressant effect on the central nervous system.

AB817, s. 221 Section 221. 161.21 (title) of the statutes is renumbered 961.21 (title).

AB817, s. 222 Section 222. 161.21 of the statutes is renumbered 961.21 (1m), and 961.21 (1m) (intro.), (a) and (c), as renumbered, are amended to read:

AB817,65,15 961.21 (1m) (intro.) The controlled substances board shall place add a substance in to schedule V if it finds upon finding that:

AB817,65,17 (a) The substance has low potential for abuse relative to the controlled substances listed included in schedule IV;

AB817,65,20 (c) The substance has limited physical dependence or psychological dependence liability relative to the controlled substances listed included in schedule IV.

AB817, s. 223 Section 223. 161.22 (title) of the statutes is renumbered 961.22 (title).

AB817, s. 224 Section 224. 161.22 (1) (title) of the statutes is repealed.

AB817, s. 225 Section 225. 161.22 (1) of the statutes is renumbered 961.22 (intro.) and amended to read:

AB817,66,3 961.22 (intro.) The Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in this section are included in schedule V.:

AB817, s. 226 Section 226. 161.22 (1m) of the statutes is renumbered 961.22 (1m), and 961.22 (1m) (intro.), as renumbered, is amended to read:

AB817,66,11 961.22 (1m) Narcotic drugs. (intro.) Unless specifically excepted under federal regulations or unless listed in another schedule, Any material, compound, mixture or preparation containing any quantity of any of the following substances or, including any of their salts, isomers or and salts of isomers, if salts, isomers or salts of isomers exist under that are theoretically possible within the specific chemical designation.:

AB817, s. 227 Section 227. 161.22 (2) of the statutes is renumbered 961.22 (2), and 961.22 (2) (intro.), as renumbered, is amended to read:

AB817,66,21 961.22 (2) Narcotic drugs containing nonnarcotic active medicinal ingredients. (intro.) Any compound, mixture or preparation containing limited quantities of any of the following narcotic drugs or their salts, isomers or salts of isomers, in limited quantities as set forth below, calculated as the free anhydrous base or alkaloid, which also contains one or more nonnarcotic, active medicinal ingredients in sufficient proportion to confer upon the compound, mixture or preparation, valuable medicinal qualities other than those possessed by the narcotic drug alone:

AB817, s. 228 Section 228. 161.23 of the statutes is renumbered 961.23, and 961.23 (4), as renumbered, is amended to read:

AB817,67,4 961.23 (4) That any person purchasing such a substance at the time of purchase present to the seller that person's correct name and address. The seller shall record the name and address and the name and quantity of the product sold. The purchaser and the seller shall sign the record of this transaction. The giving of a false name or false address by the purchaser shall be prima facie evidence of a violation of s. 161.43 961.43 (1) (a).

AB817, s. 229 Section 229. 161.24 of the statutes is renumbered 961.24 and amended to read:

AB817,67,11 961.24 (title) Republishing Publishing of updated schedules. The controlled substances board shall revise and republish the publish updated schedules annually. The failure of the controlled substances board to publish an updated schedule under this section is not a defense in any administrative or judicial proceeding under this chapter.

AB817, s. 230 Section 230. Subchapter III (title) of chapter 161 [precedes 161.31] of the statutes is renumbered subchapter III (title) of chapter 961 [precedes 961.31].

AB817, s. 231 Section 231. 161.31 of the statutes is renumbered 961.31.

AB817, s. 232 Section 232. 161.32 of the statutes is renumbered 961.32.

AB817, s. 233 Section 233. 161.335 of the statutes is renumbered 961.335, and 961.335 (4) (c), as renumbered, is amended to read:

AB817,67,19 961.335 (4) (c) The controlled substances to be used in the project, by name if included in schedule I, and by name or schedule if included in any other schedule.

AB817, s. 234 Section 234. 161.36 of the statutes is renumbered 961.36 and amended to read:

AB817,68,2 961.36 Diversion control and prevention. (1) The controlled substances board shall regularly prepare and make available to state regulatory, licensing and law enforcement agencies descriptive and analytic reports on the potential for diversion and actual diversion patterns and trends of distribution, diversion and abuse within the state of certain controlled substances the board selects that are listed in s. 161.16, 161.18, 161.20 or 161.22 961.16, 961.18, 961.20 or 961.22.

AB817,68,14 (2) The controlled substances board shall enter into written agreements with other local, state or and federal agencies to improve the identification of sources of diversion and to improve enforcement of and compliance with this chapter and other laws and regulations pertaining to unlawful conduct involving controlled substances. An agreement must specify the roles and responsibilities of each agency that has information or authority to identify, prevent or control drug diversion and drug abuse. The board shall convene periodic meetings to coordinate a state diversion prevention and control program. The board shall assist and promote coordination of cooperation and exchange of information among agencies responsible for ensuring compliance with controlled substances law, to monitor observance of these laws and to monitor cooperation between the agencies and with other states and the federal government.

AB817,68,20 (3) The controlled substances board shall evaluate the outcome of its program under this section and shall annually submit a report to the chief clerk of each house of the legislature, for distribution to the legislature under s. 13.172 (3), on its findings with respect to its effect on distribution and abuse of controlled substances, including recommendations for improving control and prevention of the diversion of controlled substances.

AB817, s. 235 Section 235. 161.38 (title) of the statutes is renumbered 961.38 (title).

AB817, s. 236 Section 236. 161.38 (1) of the statutes is renumbered 961.38 (1r) and amended to read:

AB817,69,3 961.38 (1r) Except when dispensed directly by a practitioner, other than a pharmacy, to an ultimate user, no controlled substance included in schedule II may be dispensed without the written prescription of a practitioner.

AB817, s. 237 Section 237. 161.38 (2) of the statutes is renumbered 961.38 (2) and amended to read:

AB817,69,11 961.38 (2) In emergency situations, as defined by rule of the pharmacy examining board, schedule II drugs may be dispensed upon oral prescription of a practitioner, reduced promptly to writing and filed by the pharmacy. Prescriptions shall be retained in conformity with rules of the pharmacy examining board promulgated under s. 161.31 961.31. No prescription for a schedule II substance may be refilled.

AB817, s. 238 Section 238. 161.38 (3) of the statutes is renumbered 961.38 (3).

AB817, s. 239 Section 239. 161.38 (4) of the statutes is renumbered 961.38 (4) and amended to read:

AB817,69,17 961.38 (4) A controlled substance included in schedule V shall not may be distributed or dispensed other than only for a medical purpose, including medical treatment or authorized research.

AB817, s. 240 Section 240. 161.38 (5) of the statutes is renumbered 961.38 (5).

AB817, s. 241 Section 241. 161.39 of the statutes is renumbered 961.39, and 961.39 (3) (b), as renumbered, is amended to read:

AB817,69,22 961.39 (3) (b) The indicated use of the controlled substance classified included in schedule III, IV or V so prescribed.

AB817, s. 242 Section 242. Subchapter IV (title) of chapter 161 [precedes 161.41] of the statutes is renumbered subchapter IV (title) of chapter 961 [precedes 961.41].

AB817, s. 243 Section 243. 161.41 (title) of the statutes is renumbered 961.41 (title).

AB817, s. 244 Section 244. 161.41 (1) of the statutes is renumbered 961.41 (1) and amended to read:

AB817,70,6 961.41 (1) (title) Manufacture, distribution or delivery. Except as authorized by this chapter, it is unlawful for any person to manufacture, distribute or deliver a controlled substance or controlled substance analog. Any person who violates this subsection with respect to:

AB817,70,10 (a) Except as provided in par. (d), a controlled substance classified included in schedule I or II which is a narcotic drug, or a controlled substance analog of a controlled substance included in schedule I or II which is a narcotic drug, may be fined not more than $25,000 or imprisoned for not more than 15 years or both;.

AB817,70,14 (b) Except as provided in pars. (cm) and (e) to (h), any other controlled substance classified included in schedule I, II or III, or a controlled substance analog of any other controlled substance included in schedule I or II, may be fined not more than $15,000 or imprisoned for not more than 5 years or both;.

AB817,70,17 (cm) A controlled substance under s. 161.16 (2) (b) Cocaine or cocaine base, or a controlled substance analog of cocaine or cocaine base, is subject to the following penalties if the amount manufactured, distributed or delivered is:

AB817,70,20 1. If the amount manufactured or delivered is 5 Five grams or less, the person shall be fined not more than $500,000 and shall may be imprisoned for not more than 10 years.